Advanced Malignant Solid Tumors Completed Phase 1 / 2 Trials for Neratinib (DB11828)

IndicationStatusPhase
DBCOND0036787 (Advanced Malignant Solid Tumors)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00706030Study Evaluating Neratinib (HKI-272) In Combination With Vinorelbine In Subjects With Solid Tumors And Metastatic Breast CancerTreatment
NCT00445458A Phase 1/2 Study of HKI-272 (Neratinib) in Combination With Paclitaxel (Taxol) in Subjects With Solid Tumors and Breast CancerTreatment